CABALETTA BIO INC (CABA) Stock Analyst Ratings
USA - NASDAQ:CABA - US12674W1099 - Common Stock
2.47 USD
+0.04 (+1.65%)
2.4996 USD
+0.03 (+1.2%)
ChartMill assigns a Buy % Consensus number of 84% to CABA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.5. This target is 405.87% above the current price.
CABA was analyzed by 16 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CABA.
In the previous month the buy percentage consensus was at a similar level.
CABA was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-31 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-10-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-08-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-16 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-16 | Citigroup | Maintains | Buy -> Buy |
| 2025-05-15 | Guggenheim | Maintains | Buy -> Buy |
| 2025-04-01 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-01 | UBS | Maintains | Buy -> Buy |
| 2025-04-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-01 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-20 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2024-12-19 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-10 | UBS | Initiate | Buy |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-08-12 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-08-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-21 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-17 | Stifel | Maintains | Buy -> Buy |
| 2024-06-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
CABALETTA BIO INC / CABA FAQ
What is the average price target for CABALETTA BIO INC (CABA) stock?
16 analysts have analysed CABA and the average price target is 12.5 USD. This implies a price increase of 405.87% is expected in the next year compared to the current price of 2.47.
How do analysts rate CABALETTA BIO INC (CABA)?
The consensus rating for CABALETTA BIO INC (CABA) is 83.75 / 100 . This indicates that analysts generally have a positive outlook on the stock.